DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Methadone Hydrochloride is a drug marketed by Hikma, Lannett Co Inc, Specgx Llc, Vistapharm, Akorn, Mylan Institutional, Mallinckrodt Inc, Ascent Pharms Inc, Aurolife Pharma Llc, Epic Pharma Llc, Nostrum Labs Inc, Roxane, Sun Pharm Industries, and Thepharmanetwork Llc. and is included in twenty-eight NDAs.
The generic ingredient in METHADONE HYDROCHLORIDE is methadone hydrochloride. There are thirteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the methadone hydrochloride profile page.
A generic version of METHADONE HYDROCHLORIDE was approved as methadone hydrochloride by ROXANE on March 8th, 1983.
Summary for METHADONE HYDROCHLORIDE
|Finished Product Suppliers / Packagers:||17|
|Raw Ingredient (Bulk) Api Vendors:||24|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for METHADONE HYDROCHLORIDE|
|What excipients (inactive ingredients) are in METHADONE HYDROCHLORIDE?||METHADONE HYDROCHLORIDE excipients list|
|DailyMed Link:||METHADONE HYDROCHLORIDE at DailyMed|
Recent Clinical Trials for METHADONE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|University of Sao Paulo General Hospital||Phase 3|
|Milton S. Hershey Medical Center||Early Phase 1|
|Aarhus University Hospital||Phase 4|